Iomai shares surge on premium buyout offer
ibtimes.com     May 13, 2008            

NEW YORK (AP) - Shares of Iomai Corp. surged Tuesday after the biotechnology company said vaccine maker Intercell AG offered a buyout deal of $189 million, a sharp premium for the shares. The stock rose $3.42, more than doubling to close at $6.34, approaching Intercell's proposed buyout price of... [read full story]                    


View all news articles about*:
Acquisitions Banking Buyouts Capital Changes Finance Financial Insurance Investing Issues Markets Medicines Mergers Ownership Pharmaceuticals Price Remedies Renshaw Rodman Stock Vaccines
*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies

View other selected articles:

California First National Bancorp Announces Preliminary Results of Its Tender Offer

centredaily.com     26 mins ago          

California First National Bancorp (NASDAQ: CFNB) ("CalFirst Bancorp" or the "Company") today announced the preliminary results of its modified Dutch auction tender offer, which expired at 5:00 p.m., New York City time, on...                    

comments

Cypress Bioscience: About To Reverse Course?

seekingalpha.com     1 hr ago          

Badger The Lion submits:Cypress Bioscience, Inc. (CYPB) is a favored stock for selling covered calls. But on Thursday (8/14) and Friday (8/15) last week, 1,000 Dec. call options and 1,000 Dec. put options at the strike price of...                    

comments

                   

Saxo Bank's Half-Year Results up by 57 Percent (PR Newswire)

yahoo.com     12 mins ago   1 related          

Thursday August 21, 6:00 am ET COPENHAGEN, August 21 /PRNewswire/ -- Saxo Bank today reported half-year results showing a profit before tax of DKK 162 million (EUR 21,7 million) in the first six months of 2008. In addition,...                    

comments

Semis Finding Big Growth Overseas (Zacks.com)

yahoo.com     15 mins ago          

Thursday August 21, 1:00 am ET By Abdul Saleh Zacks senior semiconductor industry analyst Abdul Saleh was on hand recently to give us his updated viewpoint of this sector. Among companies in my coverage, this would be referring...                    

comments